The 36-month beta value for XRAY is at 1.03. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 5 rating it as “overweight,” 4 as “hold,” and 1 as “sell.”
The public float for XRAY is 201.19M, and currently, shorts hold a 7.81% of that float. The average trading volume for XRAY on August 13, 2024 was 2.90M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
XRAY) stock’s latest price update
DENTSPLY Sirona Inc (NASDAQ: XRAY)’s stock price has decreased by -0.70 compared to its previous closing price of 24.13. However, the company has seen a -2.12% decrease in its stock price over the last five trading sessions. zacks.com reported 2024-08-05 that Explore how Dentsply’s (XRAY) revenue from international markets is changing and the resulting impact on Wall Street’s predictions and the stock’s prospects.
XRAY’s Market Performance
DENTSPLY Sirona Inc (XRAY) has seen a -2.12% fall in stock performance for the week, with a -6.15% decline in the past month and a -14.09% plunge in the past quarter. The volatility ratio for the week is 3.67%, and the volatility levels for the past 30 days are at 3.45% for XRAY. The simple moving average for the past 20 days is -7.41% for XRAY’s stock, with a -21.66% simple moving average for the past 200 days.
Analysts’ Opinion of XRAY
Many brokerage firms have already submitted their reports for XRAY stocks, with Leerink Partners repeating the rating for XRAY by listing it as a “Outperform.” The predicted price for XRAY in the upcoming period, according to Leerink Partners is $42 based on the research report published on February 26, 2024 of the current year 2024.
Needham, on the other hand, stated in their research note that they expect to see XRAY reach a price target of $35. The rating they have provided for XRAY stocks is “Buy” according to the report published on November 16th, 2023.
XRAY Trading at -7.64% from the 50-Day Moving Average
After a stumble in the market that brought XRAY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.64% of loss for the given period.
Volatility was left at 3.45%, however, over the last 30 days, the volatility rate increased by 3.67%, as shares sank -6.26% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.66% lower at present.
During the last 5 trading sessions, XRAY fell by -2.12%, which changed the moving average for the period of 200-days by -26.62% in comparison to the 20-day moving average, which settled at $25.80. In addition, DENTSPLY Sirona Inc saw -32.68% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at XRAY starting from LUCIER GREGORY T, who purchase 8,212 shares at the price of $24.35 back on Aug 08 ’24. After this action, LUCIER GREGORY T now owns 66,661 shares of DENTSPLY Sirona Inc, valued at $199,983 using the latest closing price.
LUCIER GREGORY T, the Director of DENTSPLY Sirona Inc, purchase 3,577 shares at $27.95 during a trade that took place back on May 31 ’24, which means that LUCIER GREGORY T is holding 58,374 shares at $99,976 based on the most recent closing price.
Stock Fundamentals for XRAY
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.52 for the gross margin
The net margin for DENTSPLY Sirona Inc stands at -0.05. The total capital return value is set at -0.02. Equity return is now at value -5.47, with -2.54 for asset returns.
Based on DENTSPLY Sirona Inc (XRAY), the company’s capital structure generated 0.41 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at 0.69. The interest coverage ratio of the stock is -1.29.
Currently, EBITDA for the company is 638.0 million with net debt to EBITDA at 4.0. When we switch over and look at the enterprise to sales, we see a ratio of 1.74. The receivables turnover for the company is 6.59for trailing twelve months and the total asset turnover is 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.33.
Conclusion
In conclusion, DENTSPLY Sirona Inc (XRAY) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
